By The Online Investor Staff, updated Thu., Oct. 27, 12:51 AM
Slide #1. Ra Pharmaceuticals, Inc. — Initial Public Offering
||Ra Pharmaceuticals, Inc.
|Price Per Share:
||Ra Pharmaceuticals, Inc. ("Ra Pharmaceuticals" or "Ra"), a clinical stage biopharmaceutical company focusing on using its proprietary peptide chemistry platform to develop novel therapeutics for the treatment of serious diseases that are caused by excessive or uncontrolled activation of the complement system, a critical component of the immune system, today announced the pricing of its initial public offering of 7,049,230 shares of common stock at a public offering price of $13.00 per share. In addition, Ra has granted the underwriters a 30-day option to purchase up to 1,057,385 additional shares of common stock at the initial public offering price, less the underwriting discount. Ra's common stock is expected to begin trading on the NASDAQ Global Market under the ticker symbol "RARX" on October 26, 2016.
IPOs: Ra Pharmaceuticals, Inc.
List of IPOs in this Slideshow:
Company Ticker IPO Date
Fulgent Genetics FLGT
Obalon Therapeutics, Inc. OBLN
Advanced Disposal Services, Inc. ADSW
Coupa Software Incorporated COUP
AquaVenture Holdings Limited WAAS
Everspin Technologies, Inc. MRAM
Avista Healthcare Public Acquisition Corp.AHPAU
Extraction Oil & Gas, Inc. XOG
AzurRx BioPharma Inc. AZRX
Mammoth Energy Services, Inc. TUSK
CRISPR Therapeutics AG CRSP
Forterra, Inc. FRTA
iRhythm Technologies, Inc. IRTC
Ra Pharmaceuticals, Inc. RARX
October 27, 2016 12:51 AM Eastern